ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08715
0,04%
Bitcoin
66.926,40
2,59%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Spring Bank Pharmaceuticals Inc (SBPH)

  7. Spring Bank Pharmaceuticals Inc (SBPH) News

SBPH

Spring Bank Pharmaceutic... (SBPH)

Spring Bank Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SBPH
DatumZeitQuelleÜberschriftSymbolFirma
17/03/202321h24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
14/03/202311h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
14/03/202311h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
14/03/202311h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
14/03/202311h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
14/03/202311h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202315h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202315h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202315h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202315h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202315h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202315h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h43Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h41Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h33Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h22Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202314h08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
07/03/202315h19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
07/03/202315h12Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
07/03/202315h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
06/03/202315h45Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
23/02/202314h46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
23/02/202314h34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
23/02/202314h02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SBPH

Kürzlich von Ihnen besucht

USOTC
RHHBY
Roche (QX)
TG
RHM
Rheinmetall
TG
BAYN
Bayer
FX
EURGBP
Euro vs Sterling
TG
TUI1
Tui
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
TG
BAS
BASF
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
CCOM
US500
US 500
TG
LHA
Deutsche Lufthansa
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten